Cybin’s (NYSE: CYBN) deuterated psychedelics programs received two patent grants from the United States Patent and Trademark Office (USPTO,) and one from the European Patent Office (EP.)
Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
TORONTO & LONDON, October 23, 2023 Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin", or the "Company") and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) ("Small Pharma") are pleased to announce the completion of the previously-announced acquisition by Cybin of Small Pharma by way of a plan of arrangement under the Business Corporations Act (British Columbia), and pursuant to the terms of an arrangement agreement dated August 28, 2023 between Cybin and Small Pharma (the "Arrangement"). As a resu
This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17,.